Molecular mechanisms of inherited arrhythmias

Current Genomics

Volumn 9, Issue 3, 2008, Pages 160-168

  Wolf, Cordula M ^a   Berul, Charles I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ANKYRIN 2; ANKYRIN B; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL CAV1.2; CATECHOLAMINE; CAVEOLIN 3; DESMOPLAKIN; GAP JUNCTION PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL KCNJ2; LAMIN A; LAMIN C; NEUROLEPTIC AGENT; PLAKOGLOBIN; PLAKOPHILIN; PLAKOPHILIN 2; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KVLQT1; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; SODIUM CHANNEL; SODIUM CHANNEL SCN5A;

ANDERSEN SYNDROME; ARRHYTHMOGENESIS; ARTIFICIAL HEART PACEMAKER; BASAL CELL NEVUS SYNDROME; BRUGADA SYNDROME; CARDIOMYOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CELL THERAPY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HEART ARRHYTHMIA; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC HEART VENTRICLE FIBRILLATION; LONG QT SYNDROME; MOLECULAR DYNAMICS; MYOPATHY; NONHUMAN; PALLIATIVE THERAPY; PHARMACOGENOMICS; QT PROLONGATION; REVIEW; TIMOTHY SYNDROME; TORSADE DES POINTES; VIRAL GENE DELIVERY SYSTEM;

ANIMALIA;

EID: 46049089627     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920208784340768     Document Type: Review

References (84)

1. Schwartz, P.J., Priori, S.G., Spazzolini, C., Moss, A.J., Vincent, G.M., Napolitano, C., Denjoy, I., Guicheney, P., Breithardt, G., Keating, M.T., Towbin, J.A., Beggs, A.H., Brink, P., Wilde, A.A., Toivonen, L., Zareba, W., Robinson, J.L., Timothy, K.W., Corfield, V., Wattanasirichaigoon, D., Corbett, C., Haverkamp, W., Schulze-Bahr, E., Lehmann, M.H., Schwartz, K., Cournel, P., Bloise, R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103: 89-95.
2. Priori, S.G., Schwartz, P.J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., Folli, R., Cappelletti, D. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 2003, 348: 1866-1874.
3. Priori, S.G., Napolitano, C., Schwartz, P.J., Grillo, M., Bloise, R., Ronchetti, E., Moncalvo, C., Tulipani, C., Veia, A., Bottelli, G., Nastoli, J. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 2004, 292: 1341-1344.
4. Priori, S.G. Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circ. Res. 2004, 94: 140-145.
5. Brink, P.A., Crotti, L., Corfield, V., Goosen, A., Durrheim, G., Hedley, P., Heradien, M., Geldenhuys, G., Vanoli, E., Bacchini, S., Spazzolini, C., Lundquist, A.L., Roden, D.M., George, A.L., Jr., Schwartz, P.J.. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation 2005, 112: 2602-2610.
6. Herfst, L.J., Rook, M.B., Jongsma, H.J. Trafficking and functional expression of cardiac Na+ channels. J. Mol. Cell. Cardiol. 2004, 36: 185-193.
7. Nerbonne, J.M., Nichols, C.G., Schwarz, T.L., Escande, D. Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here? Circ. Res. 2001, 89: 944-956.
8. Tamargo, J., Caballero, R., Gomez, R., Valenzuela, C., Delpon, E. Pharmacology of cardiac potassium channels. Cardiovasc. Res. 2004, 62: 9-33.
9. Pogwizd, S.M. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in. rabbits. Circulation 1995, 92: 1034-1048.
10. Seidman, J.G., Seidman, C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104: 557-567.
11. Maron, B.J., Gardin, J.M., Flack, J.M., Gidding, S.S., Kurosaki, T.T., Bild, D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995, 92: 785-789.
12. Maron, B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
13. Swynghedauw, B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 1999, 79: 215-262.
14. Knollmann, B.C., Roden, D.M. A genetic framework for improving arrhythmia therapy. Nature 2008, 451: 929-936.
15. Wu, T.J., Ong, J.J., Hwang, C., Lee, J.J., Fishbein, M.C., Czer, L., Trento, A., Blanche, C., Kass, R.M., Mandel, W.J., Karagueuzian, H.S., Chen, P.S. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J. Am. Coll. Cardiol. 1998, 32: 187-196.
16. Spirito, P., Seidman, C.E., McKenna, W.J., Maron, B.J. The management of hypertrophic cardiomyopathy. N. Engl. J. Med. 1997, 336: 775-785.
17. Wolf, C.M., Moskowitz, I.P., Arno, S., Branco, D.M., Semsarian, C., Bernstein, S.A., Peterson, M., Maida, M., Morley, G.E., Fishman, G., Berul, C.I., Seidman, C.E., Seidman, J.G. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia. Proc. Natl. Acad. Sci. USA 2005, 102: 18123-18128.
18. Swynghedauw, B. Remodeling of the heart in chronic pressure overload. Basic. Res. Cardiol. 1991, 86(Suppl 1): 99-105.
19. Fatkin, D., McConnell, B.K., Mudd, J.O., Semsarian, C., Moskowitz, I.G., Sohoen, F.J., Giewat, M., Seidman, C.E., Seidman, J.G. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. J Clin. Invest. 2000, 106: 1351-1359.
20. 2+-dependent action potential remodeling. Circ. Res. 2003, 92: 428-436.
21. Towbin, J.A., Bowles, N.E. The failing heart. Nature 2002, 415: 227-233.
22. Li, D., Tapscoft, T., Gonzalez, O., Burch, P.E., Quinones, M.A., Zoghbi, W.A., Hill, R., Bachinski, L.L., Mann, D.L., Roberts, R. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999, 100: 461-464.
23. Calaghan, S.C., Belus, A., White, E. Do stretch-induced changes in intracellular calcium modify the electrical activity of cardiac muscle? Prog. Biophys. Mol. Biol. 2003, 82: 81-95.
24. Raffaele, D.B., Ricci, E., Galluzzi, G., Tonali, P., Mora, M., Morandi, L., Romorini, A., Voit, T., Orstavik, K.H., Merlini, L., Trevisan, C., Biancalana, V., Housmanowa-Petrusewicz, I., Bione, S., Ricotti, R., Schwartz, K., Bonne, G., Toniolo, D. Different mutations in the LMNA gene cause autosomal dominant and autosomat recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 2000, 66: 1407-1412.
25. MacLeod, H.M., Culley, M.R., Huber, J.M., McNally, E.M. Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC. Med. Genet. 2003, 4:4.
26. Fatkin D., MacRae, C., Sasaki, T., Wolff, M.R., Porcu, M., Frenneaux, M., Atherton, J., Vidaillet, H.J., Jr., Spudich, S., De Girolami, U., Seidman, J.G., Seidman, C., Muntoni, F., Muehle, G., Johnson, W., McDonough, B. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system-disease. N. Engl. J. Med. 1999, 341: 1715-1725.
27. Arbustini, E., Pilotto, A., Repetto, A., Grasso, M., Negri, A., Diegoli, M., Camapana, C., Scelsi, L., Baldini, E., Gavazzi, A., Tavazzi, L. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J. Am. Coll. Cardiol. 2002, 39, 981-990.
28. Chen L., Lee L., Kudlow B.A., Dos Santos, H.G., Sletvold, O., Shafeghati, Y., Botha, E.G., Garg, A., Hanson, N.B., Martin, G.M., Mian, I.S., Kennedy, B.K., Oshima, J. LMNA mutations in atypical Werner's syndrome. Lancet 2003, 362: 440-445.
29. Wolf, C.M., Wang, L., Alcalai, R., Pizard, A., Burgon, P.G., Ahmad, F., Sherwood, M., Branco, D.M., Wakimoto, H., Fishman, G.I., See, V., Stewart, C.L., Conner, D.A., Berul, C.I., Seidman, C.E., Seidman, J.G. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. J. Mol. Cell. Cardiol. 2008, 44: 293-303.
30. Tiso, N., Stephan, D.A., Nava, A., Bagattin, A., Devaney, J.M., Stanehi, F., Larderet, G., Brahmbhatt, B., Brown, K., Bauce, B., Muriago, M., Basso, C., Thiene, G., Danieli, G.A., Rampazzo, A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 2001, 10: 189-194.
31. Thiene, G., Nava, A., Corrado, D., Rossi, L., Pennelli, N. Right ventricular cardiomyopathy and sudden death in young people. N. Engl. J. Med. 1988, 318: 129-133.
32. Paul, M., Schulze-Bahr, E., Breithardt, G., Wichter, T. Genetics of arrhythmogenic right ventricular cardiomyopathy - status quo and future perspectives. Z. Kardiol. 2003, 92: 128-136.
33. McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., Norman, M., Baboonian, C., Jeffery, S., McKenna, W.J. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000, 355: 2119-2124.
34. Rampazzo, A., Nava, A., Malacrida, S., Beffagna, G., Bauce, B., Rossi, V., Zimbello, R., Simionati, B., Basso, C., Thiene, G., Towbin, J.A., Danieli, G.A. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 2002, 71: 1200-1206.
35. Norgett, E.E., Hatsell, S.J., Carvajal-Huerta, L., Cabezas, J.C., Common, J., Purkis, P.E., Whittock, N., Leigh, I.M., Stevens, H.P., Kelsell, D.P. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiompathy, woolly hair and keratoderma. Hum. Mol. Genet. 2000, 9: 2761-2766.
36. Dalal, D., Molin, L.H., Piccini, J., Tichnell, C., James, C., Bomma, C., Prakasa, K., Towbin, J.A., Marcus, F.I., Spevak, P.J., Bluemke, D.A., Abraham, T., Russell, S.D., Calkins, H., Judge, D.P. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 2006, 113: 1641-1649.
37. Splawski, I., Shen, J., Timothy, K.W., Lehmann, M.H., Priori, S., Robinson, J.L., Moss, A.J., Schwartz, P.J., Towbin, J.A., Vincent, G.M., Keating, M.T. Spectrum of mutations in long-QT syndrome genes. KVLQTI, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000, 102: 1178-1185.
38. Chouabe, C., Neyroud, N., Guicheney, P., Lazdunski, M., Romey, G., Barhanin, J. Properties of KvLQT1 K+ channel mutations in Romano-Ward-and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J. 1997, 16: 5472-5479.
39. Shalaby, F.Y., Levesque, P.C., Yang, W.P., Little, W.A., Conder, M.L., Jenkins-West, T., Blanar, M.A. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation 1997, 96: 1733-1736.
40. Wollnik, B., Schroeder, B.C., Kubisch, C., Esperer, H.D., Wieacker, P., Jentsch, T.J. Pathophysiological mechanisms of dominant and recessive KVLQT1 K+ channel mutations found in inherited cardiac arrhythmias. Hum. Mol. Genet. 1997, 6: 1943-1949.
41. Sanguinetti, M.C., Curran, M.E., Spector, P.S., Keating, M.T. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad Sci. USA 1996, 93: 2208-2212.
42. Bennett, P.B., Yazawa, K., Makita, N., George, A.L., Jr. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995, 376: 683-685.
43. Dumaine, R., Wang, Q., Keating, M.T., Hartmann, H.A., Schwartz, P.J., Brown, A.M., Kirsch, G.E. Multiple mechanisms of Na+ channel-linked long-QT syndrome. Circ. Res. 1996, 78: 916-924.
44. Romano, C., Gemme, G., Pongiglione, R. Aritmiecardiache rare dell'eta pediatrica, II: accessi sincopali per fibrillazione ventricolare parossitica. Clin. Pediatr. 1963, 45: 656-683.
45. Neyroud, N., Tesson, F., Denjoy, I., Leibovici, M., Donger, C., Barhanin, J., Faure, S., Gary, F., Coumel, P., Petit, C., Schwartz, K., Guichency, P. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat. Genet. 1997, 15: 186-189.
46. Vetter, D.E., Mann, J.R., Wangemann, P., Liu, J., McLaughlin, K.J., Lesage, P., Marcus, D.C., Lazdunski, M., Heinemann, S.F., Barhanin, J. Inner ear defects induced by null mutation of the isk gene. Neuron 1996, 17: 1251-1264.
47. Mohler, P.J., Schott, J.J., Gramolini, A.O., Dilly, K.W., Guatimosim, S., DuBell, W.H., Song, L.S., Haurogne, K., Kyndt, F., Ali, M.E., Rogers, T.B., Lederer, W.J., Escande, D., Le Marec, H., Bennett, V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421: 634-639.
48. Chauhan, V.S., Tuvia, S., Buhusi, M., Bennett, V., Grant, A.O. Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice. Circ. Res. 2000, 86: 441-447.
49. Tawil, R., Ptacek, L.J., Pavlakis, S.G., DeVivo, D.C., Penn, A.S., Ozdemir, C., Griggs, R.C. Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features. Ann. Neurol. 1994, 35: 326-330.
50. Plaster, N.M., Tawil, R., Tristani-Firouzi, M., Canun, S., Bendahhou, S., Tsunoda, A., Donaldson, M.R., Iannaccone, S.T., Brunt, E., Barohn, R., Clark, J., Deymeer, F., George, A.L., Jr., Fish, F.A., Hahn, A., Nitu, A., Ozdemir, C., Serdaroglu, P., Subramony, S.H., Wolfe, G., Fu, Y.H., Ptacek, L.J. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001, 105: 511-519.
51. Splawski, L., Timothy, K.W., Sharpe, L.M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P.J., Joseph, R.M., Condouris, K., Tager-Flusberg, H., Priori, S.G., Sanguinetti, M.C., Keating, M.T. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004, 119: 19-31.
52. Vatta, M., Ackerman, M.J., Ye, B., Makielski, J.C., Ughanze, E.E., Taylor, E.W., Tester, D.J., Balijepalli, R.C., Foell, J.D., Li, Z., Kamp, T.J., Towbin, J.A. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006, 114: 2104-2112.
53. Medeiros-Domingo, A., Kaku, T., Tester, D.J., Iturralde-Torres, P., Itty, A., Ye, B., Valdivia, C., Ueda, K., Canizales-Quinteros, S., Tusie-Luna, M.T., Makielski, J.C., Ackerman, M.J. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007, 116: 134-142.
54. Westenskow, P., Splawski, I., Timothy, K.W., Keating, M.T., San-guinetti, M.C. Compound mutations: a common cause of severe long-QT syndrome. Circulation 2004, 109: 1834-1841.
55. Crotti, L., Lundquist, A.L., Insolia, R., Pedrazzini, M., Ferrandi, C., De Ferrari, G.M., Vicentini, A., Yang, P., Roden, D.M., George, A.L., Jr., Schwartz, P.J. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation 2005, 112: 1251-1258.
56. Roden, D.M. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc. Res. 2001, 50: 224-231.
57. Roden, D.M. Mechanisms and management of proarrhythmia. Am. J. Cardiol. 1998, 82: 491-571.
58. Brugada, P., Brugada, J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 1992, 20: 1391-1396.
59. Antzelevitch, C. The Brugada syndrome: diagnostic criteria and cellular mechanisms. Eur. Heart J. 2001, 22: 356-363.
60. Alings, M., Wilde, A. "Brugada" syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999, 99: 666-673.
61. Priori, S.G., Napolitano, C., Gasparani, M., Pappone, C., Della, B.P., Giordano, U., Bloise, R., Giustetto, C., De Nardis, R., Grillo, M., Ronchetti, E., Faggiano, G., Nastoli, J. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002, 105: 1342-1347.
62. Napolitano, C., Rivolta, I., Priori, S.G. Cardiac sodium channel diseases. Clin. Chem. Lab. Med. 2003, 41: 439-444.
63. London, B., Michalec, M., Mchdi, H., Zhu, X., Kerchner, L., Sanyal, S., Viswanathan, P.C., Pfahnl, A.E., Shang, L.L., Madhusudanan, M., Baty, C.J., Lagana, S., Alcong, R., Gutmann, R., Ackerman, M.J., McNamara, D.M., Weiss, R., Dudley, S.C., Jr. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias, Circulation 2007, 116; 2260-2268.
64. Leenhardt, A., Lucet, V., Denjoy, L., Grau, F., Ngoc, D.D., Coumel, P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995, 91: 1512-1519.
65. Priori, S.G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R., Cruz Filho, F.E., Vignati, G., Benatar, A., DeLogu, A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002, 106: 69-74.
66. Priori, S.G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrentino, V., Danich, G.A. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001, 103: 196-200.
67. Lahat, H., Pras, E., Olender, T., Avidan, N., Ben Asher, E., Man, O., Levy-Nissenbaum, E., Khoury, A., Lorber, A., Goldman, B., Lancet, D., Eldar, M. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am. J. Hum. Genet. 2001, 69: 1378-1384.
68. Liu, N., Colombi, B., Memmi, M., Zissimopoulos, S., Rizzi, N., Negri, S., Imbriani, M., Napolitano, C., Lai, F.A., Priori, S.G. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model. Circ. Res. 2006, 99: 292-298.
69. Song, L., Alcalai, R., Arad, M., Wolf, C.M., Toka, O., Conner, D.A., Berul, C.I., Eldar, M., Seidman, C.E., Seidman, J.G. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J. Clin. Invest. 2007, 117: 1814-1823.
70. Wever, E.F., Robles de Medina, E.O. Sudden death in patients without structural heart disease. J. Am. Coll. Cardiol. 2004, 43: 1137-1144.
71. Wever, E.F., Hauer, R.N., Oomen, A., Peters, R.H., Bakker, P.F., Robles de Medina, E.O. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventnicular fibrillation. Circulation 1993, 88: 1021-1029.
72. Chen, Q., Kirsch, G.E., Zhang, D., Brugada, R., Brugada, J., Brugada, P., Potenza, D., Moya, A., Borggrefe, M., Breithardt, G., Ortiz-Lopez, R., Wang, Z., Antzelevitch, C., O'Brien, R.E., Schulze-Bahr, E., Keating, M.T., Towbin, I. A., Wang, Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998, 392: 293-296.
73. Moric-Janiszewska, E., Herbert, E., Cholewa, K., Filipecki, A., Trusz-Gluza, M., Wilczok, T. Mutational screening of SCN5A linked disorders in Polish patients and their family members. J. Appl. Genet. 2004, 45: 383-39G.
74. Viskin, S., Fish, R., Eldar, M., Zeltser, D., Lesh, M.D., Glick, A., Belhassen, B. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls. Heart 2000, 84: 31-36.
75. Sangwatanaroj, S., Yanatasneejit, P., Sunsaneewitayakul, B., Sitthisook, S. Linkage analyses and SCN5A mutations screening in five sudden unexplained death syndrome (Lai-tai) families. J. Med. Assoc. Thai. 2002, 85(Suppl 1): S54-S61.
76. Arking, D.E., Pfeufer, A., Post, W., Kao, W.H., Newton-Cheh, C., Ikeda, M., West, K., Kashuk, C., Akyol, M., Perz, S., Jalilzadeh, S., Illig, T., Gieger, C., Guo, C.Y., Larson, M.G., Wichmann, H.E., Marban, E., O'Donnell, C.J., Hirschhorn, J.N., Kaab, S., Spooner, P.M., Meitinger, T., Chakravarti, A. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat. Genet. 2006, 38: 644-651.
77. Aarnoudse, A.J., Newton-Cheh, C., de Bakker, P.I. Straus, S.M., Kors, J.A., Hofman, A., Uitterlinden, A.G., Witteman, J.C., Stricker, B.H. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 2007, 116: 10-16.
78. Sasano, T., McDonald, A.D., Kikuchi, K., Donahue, J.K. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat. Med. 2006, 12: 1256-1258.
79. Bucchi, A., Plotnikov, A.N., Shlapakova, I., Danilo, P. Jr., Kryukova, Y., Qu, J., Lu, Z., Liu, H., Pan, Z., Potapova, I., KenKnight, B., Girouard, S., Cohen, I.S., Brink, P.R., Robinson, R.B., Rosen, M.R. Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker. Circulation 2006, 114: 992-999.
80. Edelberg, J.M., Aird, W.C., Rosenberg, R.D. Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J. Clin. Invest. 1998, 101: 337-343.
81. Miake, J., Marban, E., Nuss, H.B. Biological pacemaker created by gene transfer. Nature 2002, 419: 132-133.
82. Qu, J., Plotnikov, A.N., Danilo, P., Jr, Shlapakova, I., Cohen, I.S., Robinson, R.B., Rosen, M.R. Expression and function of a biological pacemaker in canine heart. Circulation 2003, 107: 1106-1109.
83. Plotnikov, A.N., Sosunov, E.A. Qu, J., Shlapakova, I.N., Anyukhovsky, E.P., Liu, L., Janse, M.J., Brink, P.R., Cohen, I.S., Robinson, R.B., Danilo, P., Jr., Rosen, M.R. Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation 2004, 109: 506-512.
84. Potapova, I., Plotnikov, A., Lu, Z., Danilo, P., Jr., Valiunas, V., Qu, J., Doronin, S., Zuckerman, J., Shlapakova, I.N., Gao, J., Pan, Z., Herron, A.J., Robinson, R.B., Brink, P.R., Rosen, M.R., Cohen, I.S. Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ. Res. 2004, 94: 952-959.